Oncovin

Oncovin information and resources from the National Cancer Institute

Oncovin

(Other name for: vincristine)ondansetron

A carbazole derivative with antiemetic activity. As a selective serotonin receptor antagonist, ondansetron competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting. Oncovin

(Other name for: vincristine)

vincristine Eli Lilly Jul 10 1963

vincristine Eli Lilly Jul 10 1963

vincristine Eli Lilly Jul 10 1963

vincristine Eli Lilly Jul 10 1963

vincristine Eli Lilly Jul 10 1963

vincristine Eli Lilly Jul 10 1963

vincristine Eli Lilly Jul 10 1963

High-Dose GleevecÂ® and Low-Dose Chemotherapy Effective for ... Mar 17, 2006
Cancer Consultants (press release), France recently conducted a clinical trial to evaluate high-doses of Gleevec combined with low doses of the chemotherapy agent vincristine (OncovinÂ®) and the ...

Hana Biosciences To Pay Up to $42 Million For Drugs Mar 17, 2006
Forbes Marqibo contains the same active ingredient as Oncovin from Eli Lilly (nyse: LLY - news - people ), encapsulated in a new technology that could make it target ...

Hana Biosciences to License Three Targeted Cancer Drug Candidates ... Mar 17, 2006
Genetic Engineering News, Vincristine (Oncovin(R); Eli Lilly & Company), a microtubule inhibitor, is approved for acute lymphoblastic leukemia (ALL) and is widely used as a single ...

Hana Paying Up To $42M For Inexâ€™s Cancer Drugs Mar 17, 2006
BioWorld Online (subscription), Vincristine, sold as Oncovin by Indianapolis-based Eli Lilly and Co., is a microtubule inhibitor approved for acute lymphoblastic leukemia. ...

Oncovin -->